Status:
COMPLETED
S90652 in Paediatric Hypertension
Lead Sponsor:
Institut de Recherches Internationales Servier
Conditions:
Hypertension
Eligibility:
All Genders
2-16 years
Phase:
PHASE2
Brief Summary
The aim of the study is to assess the acceptability, safety and pharmacokinetics and effects on blood pressure of a paediatric formulation of perindopril given in hypertensive children
Eligibility Criteria
Inclusion
- Hypertensive children
Exclusion
- Renal failure
- Unstable renal function
- Hyperkaliemia
Key Trial Info
Start Date :
July 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2006
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT00202553
Start Date
July 1 2003
End Date
December 1 2006
Last Update
April 11 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpital Necker Enfants Malades
Paris, France